"A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 3"

CompletedOBSERVATIONAL
Enrollment

113,123

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Substance Abuse
Interventions
BEHAVIORAL

Meetings with implementation leader(s)

The perceived appropriateness of the intervention to medical staff will affect an intervention's initial adoption as well as sustainability. We will assess this through focus groups with staff, conducted approximately 1-2 months after implementation of the screening and CDS tools.

BEHAVIORAL

the SAAS survey

Medical staff will be surveyed using the Substance Abuse Attitude Survey (SAAS) to gather information about attitudes from medical staff who do not participate in the focus groups, or may be uncomfortable sharing negative attitudes in a group of their peers. The SAAS is a validated multidimensional instrument that evaluates physician attitudes toward substance-using patients. It includes specific measures of attitudes toward permissiveness, treatment intervention, stereotypes, treatment optimism, and moralism, and has been used in prior studies of primary care physicians. Collecting information on staff attitudes toward substance users and substance use interventions will be helpful to inform about any sources for low adoption of the tools, and any needs for additional provider education and training.

BEHAVIORAL

Patient surveys

Patient surveys regarding attitudes toward substance use screening and interventions in the primary care clinic will be distributed to patients presenting for care, regardless of whether they completed screening, at regular time periods throughout this study phase. The survey will be conducted for 1 week at the following approximate intervals following successful implementation: 1 month, 4 months, 7 months, and 10 months

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai, New York

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

NYU Langone Health

OTHER

NCT02963948 - "A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings (CDE-EHR-PC Study), Phase 3" | Biotech Hunter | Biotech Hunter